HAVN Life Sciences Inc. (HAVLF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0018 (-94.74%)
At close: Dec 29, 2025
HAVN Life Sciences Company Description
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.
The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds.
The company was incorporated in 2020 and is based in Port Moody, Canada.
Contact Details
Address: 605 - 130 Brew Street Port Moody, BC V3H 0E3 Canada | |
| Phone | 604 370 9520 |
| Website | havnlife.com |
Stock Details
| Ticker Symbol | HAVLF |
| Exchange | OTCMKTS |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| ISIN Number | CA4196213058 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Tim Moore | Interim Chief Financial Officer, Chief Executive Officer and Chairman |
| Jenna Pozar | Chief Operations Officer |
| Paul More | Controller |